New York Opioid Settlement Reached, Johnson & Johnson To Pay $230M

Johnson and Johnson will pay $230 million to New York according to a recent settlement agreement between the two.

Another $33 million will cover attorney fees and costs, bringing the total to $263 million.

As part of the agreement, the company has agreed not to sell opioids nationwide as part of the deal, which they said they had already stopped doing, PEOPLE reported.

“The settlement is not an admission of liability or wrongdoing by the Company,” Johnson and Johnson stated. J&J will now be removed for the upcoming trial set to start Tuesday on Long Island and involves several other big opioid distributors. The company has been named in other lawsuits in different states for its role in the nationwide opioid epidemic.

“The opioid epidemic has wreaked havoc on countless communities across New York state and the rest of the nation, leaving millions still addicted to dangerous and deadly opioids,” New York Attorney General Letitia James said in a statement announcing the settlement news Saturday.

“Johnson & Johnson helped fuel this fire, but today they’re committing to leaving the opioid business – not only in New York but across the entire country,” she added.

The funds from the $230 million settlement will go towards opioid prevention, treatment, and education efforts across the state, the statement confirmed.

“While no amount of money will ever compensate for the thousands who lost their lives or became addicted to opioids across our state or provide solace to the countless families torn apart by this crisis, these funds will be used to prevent any future devastation,” James said.